Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Tokyo Big Sight

11 nov 2018 9:30 a.m. - 13 nov 2018 5:40 p.m.

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V5-S4] What ICH E17 Would Bring to Global Drug Development

Session Chair(s)

Taro  Ishibashi, PhD, RPh

Taro Ishibashi, PhD, RPh

President

Pfizer R&D Japan, Japan

Now that ICH E17 passed Step 5, MRCTs utilizing the Guideline will be used for the global drug development from now on. The Guideline defines the fundamental rules in designing MRCTs for drug development, but it doesn’t define how the result of MRCTs should be analyzed and used for the judgment for drug approval. It will be the decision of each regulatory agency. In this session, we invite experts from various regions such as Japan, US, Europe or China, and ask them to discuss what changes this Guideline would bring to MRCTs, and what implications the Guideline would have for the submissions of new drugs. And then we will discuss what ICH E17 would bring to global drug development.

Speaker(s)

Joseph  Scheeren, PharmD

E17 Implication for Global Drug Development: US Perspective

Joseph Scheeren, PharmD

Scheeren HealthCare LLC, United States

Founder

Ling  Su, PhD

E17 Implication for Global Drug Development: China Perspective

Ling Su, PhD

Shenyang Pharmaceutical University, Yeehong Business School, China

Research Fellow

Norisuke  Kawai, PhD

E17 Implication for Global Drug Development: Statistical Consideration

Norisuke Kawai, PhD

Pfizer R&D Japan G.K., Japan

Senior Director, Head of Clinical Research

Ryuta  Nakamura, PhD

Ryuta Nakamura, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Review Director, Office of New Drug II

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.